Eagle IP is excited to sponsor and participate in IAM’s IPBC Connect, returning to Zoom for a week of high-level discussions involving the world’s leading IP experts. From 22-26 March, IAM hosted more than 20 individual interactive digital sessions, each designed to facilitate the exchange of information and insight, benchmarking and the sharing of the best practice in key areas of strategic IP value creation.

Our VP Jennifer Che spoke as an IP expert at an open discussion forum about Patent Law Update Asia, happening March 23 at 11AM HKT (March 22, 11PM EST for those in North America).

You can register for as many sessions as you like across the week, building your own schedule. Find out more here: httpss://cvent.me/VnkWam?RefId=Sponsor

Our Past Events

Recommended Insights

How Far Can an Employer Reach to Own Employee-made “Service Inventions”?

30 July 2020
2019 China’s Top 50 Representative IP Cases Shenzhen Weibang Technology Co. Ltd v. Li Jianyi & Shenzhen Yuancheng Intelligence Equipment Co. Ltd (2019最高法民申6342号) Each year in China there are hundreds of disputes over patent ownership.  A significant part of them are related to “Service Inventions”, which are defined in Article 6 of the Chinese Patent […]

How will Civil Cases Work under the Patent Linkage Provision in the New Chinese Patent Law?

20 November 2020
The Supreme People’s Court has just issued draft regulations for comment regarding how new Article 76 will work in conjunction with civil procedure law. The period to submit comments ends December 14, 2020, and the final version will come into force June 1, 2021, together with the new Chinese Patent Law. The Backdrop: New Chinese […]

Compositions Limited by Use: A Cautionary Tale

26 October 2022
Section 4.2.3, Part II Chapter 10 of the CNIPA’s Examination Guidelines (“Guidelines”) stipulates that if the specification only discloses one property or use of a composition, the composition claim shall be drafted as a “composition limited by the function or the use”. Furthermore, it specifically states that “most pharmaceutical claims shall be drafted as claims […]

China Releases Details on Patent Term Extension, Deferred Examination and More in the Latest Draft Implementation Rules of the New Chinese Patent Law

11 December 2020
The China National Intellectual Property Administration (CNIPA) is moving forward at breakneck speeds aiming to get all the necessary pieces in place for the June 1, 2021 date when the new 4th Amendment of the Patent Law will come into effect. Most recently, this means a flurry of drafts coming out from CNIPA, including, but […]
Top crossarrow-right